<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:contributor>David Sanchez-Migallon Guzman</dc:contributor>
  <dc:contributor>Heather K. Knych</dc:contributor>
  <dc:contributor>Olivia A. Petritz</dc:contributor>
  <dc:contributor>Glenn H. Olsen</dc:contributor>
  <dc:contributor>Joanne R. Paul-Murphy</dc:contributor>
  <dc:creator>Kate A. Gustavsen</dc:creator>
  <dc:date>2014</dc:date>
  <dc:description>&lt;p class="first"&gt;&lt;strong&gt;Objective&lt;/strong&gt;&amp;mdash;To determine the pharmacokinetics of buprenorphine hydrochloride after IM and IV administration to American kestrels (&lt;i&gt;Falco sparverius&lt;/i&gt;).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Animals&lt;/strong&gt;&amp;mdash;13 healthy 3-year-old captive-bred American kestrels.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Procedures&lt;/strong&gt;&amp;mdash;Buprenorphine hydrochloride (0.6 mg/kg) was administered IM to all birds. Blood samples were collected at 9 times, ranging from 5 minutes to 9 hours after drug administration. Plasma buprenorphine concentrations were measured by use of tandem liquid chromatography&amp;ndash;mass spectrometry. Pharmacokinetic parameters were determined by use of least squares linear regression and noncompartmental analysis of na&amp;iuml;ve pooled data. After a washout period of 2 weeks, the same dose of buprenorphine was administered IV to all birds and blood samples were collected at the same times after drug administration.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&amp;mdash;Maximum plasma buprenorphine concentration was achieved within 5 minutes after IM administration. For IM administration, bioavailability was 94.8% and elimination half-life was 92.1 minutes. For IV administration, steady-state volume of distribution was 4,023.8 mL/kg, plasma clearance was 49.2 mL/min/kg, and elimination half-life was 105.5 minutes.&lt;/p&gt;
&lt;p class="last"&gt;&lt;strong&gt;Conclusions and Clinical Relevance&lt;/strong&gt;&amp;mdash;Buprenorphine was rapidly absorbed, and bioavailability was good after IM administration to American kestrels. Plasma buprenorphine concentrations were &amp;gt; 1 ng/mL for 9 hours after both IM and IV administration. These results, in combination with those of a pharmacodynamic study, suggested that the analgesic effects of buprenorphine could last at least 6 to 9 hours in this species. Further investigations of the duration of analgesic effects, multiple-dose protocols, and potential adverse effects of buprenorphine are warranted in American kestrels and other raptors.&lt;/p&gt;</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>10.2460/ajvr.75.8.711</dc:identifier>
  <dc:language>en</dc:language>
  <dc:publisher>American Veterinary Medical Association</dc:publisher>
  <dc:title>Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (&lt;i&gt;Falco sparverius&lt;/i&gt;)</dc:title>
  <dc:type>article</dc:type>
</oai_dc:dc>